ipriflavone has been researched along with leuprolide in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Filippa, N; Gallina, D; Manni, M; Perotti, F; Polatti, F | 1 |
| Affinito, P; Di Carlo, C; Merlino, P; Morgera, R; Napolitano, V; Nappi, C; Palomba, S; Pellicano, M; Tremolaterra, F | 1 |
| Cappagli, B; Ciaponi, M; Gambacciani, M; Genazzani, AR; Piaggesi, L | 1 |
| Aso, T; Chiguchi, M; Ishibashi, T; Somekawa, Y; Wakana, K | 1 |
4 trial(s) available for ipriflavone and leuprolide
| Article | Year |
|---|---|
[Long-term assessment of bone loss in patients treated with GnRH agonists].
Topics: Adult; Antineoplastic Agents, Hormonal; Bone Resorption; Female; Humans; Isoflavones; Leuprolide | 1995 |
[Effects of ipriflavone on bone loss induced by GnRH analog].
Topics: Analgesics; Antineoplastic Agents, Hormonal; Bone Remodeling; Female; Genital Diseases, Female; Genital Neoplasms, Female; Humans; Isoflavones; Leuprolide; Osteoporosis; Time Factors | 1996 |
Ipriflavone prevents the loss of bone mass in pharmacological menopause induced by GnRH-agonists.
Topics: Absorptiometry, Photon; Analysis of Variance; Antineoplastic Agents, Hormonal; Bone Density; Bone Remodeling; Female; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Hypogonadism; Isoflavones; Leiomyoma; Leuprolide; Lumbar Vertebrae; Menopause; Metrorrhagia; Osteoporosis, Postmenopausal; Treatment Outcome; Uterine Neoplasms; Uterus | 1997 |
Efficacy of ipriflavone in preventing adverse effects of leuprolide.
Topics: Adult; Bone Density; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Estrogen Antagonists; Female; Humans; Isoflavones; Leiomyoma; Leuprolide; Middle Aged; Osteoporosis; Triglycerides; Uterine Neoplasms | 2001 |